. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

A Preclinical Mouse Model for use in MUC1 Immunotherapy Protocols

Reference #:

1997-112

Inventors/Contributors

Sandra J. Gendler, Ph.D., Gerald Rowse, Ph.D.

Description

An inbred strain of transgenic mice that show tissue-specific expression of the human MUC1 gene. These animals express a form of the human MUC1 gene which codes for the core protein of a mucin expressed by glandular epithelia and carcinomas which develop from these tissues. The core protein is underglycosylated in these cancers and therefore represents a possible target for immunotherapy. These transgenic animals form the basis for the development of preclinical models for evaluations of novel cancer therapies.

Patent Status

None

Contact

Julie A. Henry, Licensing Manager
henry.julie@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-4585
Fax: (507) 284-5410